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Background and objective: In Sweden, mortality from cardiovascular diseases (CVD) increased steadily during
the 20th century and in the mid-1980s it was highest in the county of Va ¨sterbotten. Therefore, a community
intervention programme was launched  the Va ¨sterbotten Intervention Programme (VIP)  with the aim of
reducing morbidity and mortality from CVD and diabetes.
Design: The VIP was first developed in the small municipality of Norsjo ¨ in 1985. Subsequently, it was
successively implemented across the county and is now integrated into ordinary primary care routines. A
population-based strategy directed towards the public is combined with a strategy to reach all middle-aged
persons individually at ages 40, 50 and 60 years, by inviting them to participate in systematic risk factor
screening and individual counselling about healthy lifestyle habits. Blood samples for research purposes are
stored at the Umea ˚ University Medical Biobank.
Results: Overall, 113,203 health examinations have been conducted in the VIP and 6,5007,000 examinations
take place each year. Almost 27,000 subjects have participated twice. Participation rates have ranged between
48 and 67%. A dropout rate analysis in 1998 indicated only a small social selection bias. Cross-sectional,
nested case-control studies and prospective studies have been based on the VIP data. Linkages between the
VIP and local, regional and national databases provide opportunities for interdisciplinary research, as well as
national and international collaborations on a wide range of disease outcomes. A large number of
publications are based on data that are collected in the VIP, many of which also use results from analysed
stored blood samples. More than 20 PhD theses have been based primarily on the VIP data.
Conclusions: The concept of the VIP, established as a collaboration between politicians and health care
providers on the one hand and primary care, functioning as the operating machinery, and the public on the
other, forms the basis for effective implementation and endurance over time. After more than 20 years of
the VIP, there is a large comprehensive population-based database, a stable organisation to conduct health
surveys and collect data, and a solid structure to enable widespread multidisciplinary and scientific
collaborations.
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I
n Sweden, mortality from cardiovascular diseases
(CVD) gradually increased from the beginning of the
20th century until the 1960s, when this trend reached
a plateau and then reversed in the mid-1980s. In the
northern counties this transition was even more marked
than in the country as a whole. Having constituted a
negligible part of total mortality at the beginning of the
20th century, cardiovascular mortality increased more
rapidly in the north starting in the early 1940s (1),
becoming the leading cause of death in the 1970s and
early 1980s. The county of Va ¨sterbotten showed the
highest mortality from myocardial infarction with 720/
100,000 inhabitants/year among 16 to 74-year-olds. By
comparison, the county of Halland, located in southern
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with almost 200 fewer deaths per year (2). In the
Va ¨sterbotten municipality of Norsjo ¨, CVD mortality
among men was even higher, and was three-fold that of
women in the area. Among the general population there
was a growing awareness of the threat of CVD.
During the 1970s, this pattern of mortality was
observed and described in social medicine and epidemio-
logical analyses (36). Scientific investigations and dis-
cussions among health policy makers and administrators
led to a collaborative project between the Va ¨sterbotten
County Council, SPRI (The Swedish Planning and
Rationalization Institute for Health Services) and the
Department of Social Medicine, Umea ˚ University. The
collaboration resulted in a report titled ‘Health problems
in a county  abasis for health planning’ (7), based on the
Swedish Causes of Death Register, the Register of
Diagnoses in In-patient Care and Survey of Living
Conditions (8). The new Health Care Act (9), provided
an additional incentive for prevention initiatives. This
legislation was adopted by the Swedish Parliament in
1982 and specified that, in addition to providing care, the
County Council was also responsible for programmes to
improve health. Subsequently, in 1984, the Va ¨sterbotten
County Council decided to launch a community inter-
vention programme  the Va ¨sterbotten Intervention
Programme (VIP)  with the aim of reducing morbidity
and mortality from CVD and diabetes (10). Initially, the
intervention would be developed in a small municipality,
Norsjo ¨, where the programme would be evaluated and
revised before successive implementation in the rest of the
county.
Va ¨sterbotten County covers one eighth of Sweden,
from the Gulf of Bothnia to the Scandinavian mountain
chain, and has an area of 55,000 km
2. The population is
concentrated in the coast land and increased slightly from
245,000 in 1985 to 258,000 in 2007.
Setting: primary care in Sweden
Primary care has a long tradition in Sweden, dating back
to the 17th century. District medical officers, who were
often responsible for huge land areas, carried out inspec-
tions and reported to the authorities about health and
diseases, lifestyle habits and sanitary and socioeconomic
conditions in the population. The number of district
medical officers increased gradually and at the turn of the
19th century there was at least one physician in each
urban or rural district. In 1973, these district officers were
replaced by family doctors working primarily in health
care centres. Primary care centres often consist of 210
doctors collaborating and working together with district
nurses, midwives, assistant nurses, physiotherapists, occu-
pational therapists and administrative personnel. Primary
care is financed by taxes and to a small extent by out-of-
pocket payments, and is organised either by each county
or by private care providers.
Primary prevention also has a long tradition in
Sweden, with well-organised antenatal and child welfare
clinics attended by almost all children and pregnant
women in the country. The main area of responsibility for
Swedish district nurses is prevention and public health
with an emphasis on children and the elderly. Therefore,
they have comprehensive knowledge about the popula-
tion within the district they serve. Approximately 50% of
the population attend their primary care centre each year
and within a few years the majority are well-known by
their family doctor and district nurse (11). However, no
systematic prevention programmes have addressed the
middle-aged population.
History of the VIP
Point of departure
The VIP, initially called the Norsjo ¨ Project, began in
1985. Descriptive analyses that showed high CVD
mortality in Va ¨sterbotten as a whole, and in Norsjo ¨ in
particular, were presented to leading physicians, politi-
cians and administrators, social and health workers and
the public. The discussions that followed created positive
conditions for local initiatives and action by multiple
sectors. A series of local meetings were held in Norsjo ¨ and
the surrounding villages, and the public was invited to
participate with regard to the contents of the VIP.
Alternative explanations for the high CVD mortality
were put forward by the public, e.g. pollutants from the
mining industry (12), however, a general understanding
of the associations between risk factors and CVD
gradually increased (13).
From the beginning, the Va ¨sterbotten model for
prevention combined a population-based strategy direc-
ted towards the public with a strategy to reach all middle-
aged persons individually by inviting them to participate
in screening and health counselling conducted by their
primary health care providers.
The population-oriented activities were co-ordinated
within a framework of the intervention programme and
consisted of many components. The intervention was
tailored to local circumstances through involvement of
the whole local community, from schools to homes for
the elderly, public and private organisations, lay opinion
leaders, politicians, voluntary organisations, industrial
entrepreneurs and tradesmen. The process was integrated
into everyday activities and aimed at health promotion
(14). For example, schools and pre-schools developed
more varied and healthier menus for school lunches, local
associations organised health information meetings for
their members and were supported in producing informa-
tional materials about various health issues. Educational
materials were also produced for local study groups
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health problems and health care, and food traditions and
basic nutrition.
In agreement with the County Council, primary health
centre staff assumed responsibility for inviting all in-
habitants to participate in a comprehensive health survey
every 10 years, at ages 30, 40, 50 and 60 years. The
fundamental idea was that opportunities for intervention
would be established at the local primary care centre,
where systematic risk factor screening and individual
counselling about healthy lifestyle habits could influence
the risk of CVD at both population and individual levels.
The VIP administrators had an open attitude towards
the media, which resulted in a number of articles in the
local and national press (13). The main participants in
these articles were the authorities, including medical staff,
and the focus was mainly on middle-aged men and
individual lifestyle habits. Little space was given in the
media to women, children and people of 60. Collabora-
tions with the local food production industry and
merchants, as well as the National Food Administration
in Sweden (Livsmedelsverket), resulted in a food labelling
system for low-fat and high-fibre products. This system,
known as ‘the green keyhole’, was introduced in Norsjo ¨
in 1987 and then further developed and introduced across
the rest of Sweden (Fig. 1).
Implementation throughout the rest of the county
Based on the experiences in Norsjo ¨ and how the model
worked in practice, the VIP was gradually implemented
throughout the county, starting in 1987. Since 1991, the
programme has covered the entire middle-aged popula-
tion (15) (Fig. 2). As part of a dissemination programme,
various launch events were directed at the general
population and introduced in each municipality. Among
other things, this included public information meetings,
activities in non-governmental organisations, and invita-
tions to study groups and physical activities. Activities in
the local community were most intense during the early
years of the VIP, particularly in the pilot area of Norsjo ¨.
Initially, the VIP was characterised as a project, and
health surveys could be discontinued for periods of time
due to decisions at each health centre. This contributed to
decreased participation rates, i.e. 4857% during 1991
1995. In order to give priority to prevention efforts, the
County Council decided to integrate the VIP into
ordinary primary care routines in 1995. At the same
time, it was also decided to omit individuals aged 30 due
to low attendance rates and budgetary restrictions.
Thereafter, participation rates increased and have re-
mained at 6667% since 2005. Between inception through
2007, a total of 86,242 individuals have participated with
almost 27,000 participating twice. Overall, 113,203 health
examinations have been conducted as part of the VIP
and an additional 6,5007,000 take place each year
(Fig. 3). Distribution between sexes and educational
groups is provided in (Table 1). Analysis of the dropout
rate in 1998 showed marginal differences in social
characteristics between participants and non-participants
and indicate only a small social selection bias (16).
Dropout analyses published in 2007 regarding long-
itudinal VIP studies showed that participants of younger
age, with more cardiovascular risk markers, who were
men or with higher education were less likely to return for
a second health examination (39, 80). Overall, the effect
of this should be complex because these characteristics
are, to some extent, contradictive, as younger age and
higher education is known to be associated with lower
cardiovascular risk.
Design of the VIP
Procedures: the health survey, manual, decision
support system, educational activities
The VIP manual
The VIP measurements and procedures follow a detailed
manual that describes procedures and indications for
extended examination or referrals and/or counselling
regarding lifestyle modification.
Invitation to participants
Eachyear, all subjects who become 40, 50 or 60 years and
who belong to the list for a specific primary care centre or
live within the area for that centre, are identified by the
County Council administrative staff, which has access to
the national population register. This register is based on
the individual civic numbers that identify all Swedes and
include name, address and date of birth. This information
is given to each health centre that, in turn, invites the
participants to the health examination.
Measurements
Participants visit their health centre following an over-
night fast. A list of procedures is given in Table 2. Height
and weight in light clothing are measured and body mass
index (BMI) in kilogram per square metre is calculated.
Blood pressure is measured once with a mercury sphyg-
momanometer after 5 min rest with the subject in a
supine position. An oral glucose tolerance test (OGTT)
following WHO standards is done with a 75-g oral
glucose load (17). Subjects with previously known
Fig. 1. The green keyhole developed from a lattice-work
heart pattern. The green keyhole designates a healthy food
item.
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(page number not for citation purpose)diabetes mellitus or with fasting glucose exceeding the
criterion for diabetes do not undergo OGTT. A Reflotron
bench-top analyser (Roche Diagnostics) is used for the
analyses of blood lipids; from 1985 to 2004 it was also
used for plasma glucose values. Currently, a Hemocue
bench-top analyser (Quest Diagnostics) is used for
glucose values. For those identified as at increased risk,
additional samples of blood are also sent to the clinical
chemistry department at the nearest local hospital for
more detailed analysis of blood lipids. Participants are
invited to donate blood for research purposes and these
samples are stored at 808C at the Umea ˚ University
Medical Biobank (18). Reflotron and Hemocue analysers
Fig. 2. Cumulative number of individuals who participated in the Va ¨sterbotten Intervention Programme and the number of
health surveys performed during the programme from 1985 to 2007. The start in Norsjo ¨ 1985 and subsequent implementation in
all municipalities in the county until 1991 is demonstrated.
Fig. 3. Number of Va ¨sterbotten Intervention Programme
health examinations of men and women aged 30, 40, 50 and
60 years between 1990 and 2007. Total number: 54,568 men
and 58,635 women.
Table 1. Number of Va ¨sterbotten Intervention Programme
health examinations of participants during three time periods
from 1990 to 2007, with distribution by sex and educational
group
19901995 19962001 20022007
Sex
Men 17,390 (47.3) 17,371 (48.2) 19,644 (49)
Women 19,378 (52.7) 18,679 (51.8) 20,458 (51)
Education
Basic 10,556 (29.3) 9,200 (25.7) 6,887 (17.3)
Mid-level 17,530 (48.7) 17,818 (49.7) 21,068 (52.9)
High 7,927 (22) 8,813 (24.6) 11,869 (29.8)
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EQUALIS, the External Quality Assurance in Labora-
tory Medicine in Sweden.
Questionnaire
The VIP participants are invited to complete a compre-
hensive questionnaire that covers socioeconomic and
psychosocial conditions, self-rated health, personal
health history and family history of CVD and diabetes,
quality of life (19, 20), social network and support
(21, 22), working conditions (23, 24), physical activity,
alcohol problems (25, 26), tobacco consumption, eating
habits and a food frequency questionnaire (27). Content
areas of the VIP questionnaire are summarised in Table 3.
Individual counselling
Each health survey concludes with information about the
results of the examination and the questionnaire is
reiterated to the participant. In the early years, this
conversation was mainly unidirectional in nature, with
nurses giving advice about adequate lifestyle changes
with a focus on single risk indicators. Methodology has
Table 2. Overview of Va ¨sterbotten Intervention Programme procedures. Recommendations are that nurses and doctors (general
practitioners, GP) use motivational interviewing (MI) when counselling lifestyle changes aimed at risk factor reduction. Doctors
are encouraged to follow current guidelines regarding pharmacological treatments
Risk indicator Variable Decision level Recommendation
Overweight/
obesity
Body mass index waist ]30 kg/m2
a MI
Men 102 cm
a, women  88 cm
a
Hypertension Systolic, diastolic blood pressure,
ongoing antihypertensive medication
a
]140/90
a Two follow-up visits to
nurse then referral to GP if
blood pressure
remains elevated, MI
]130/80 for participants with diabetes Referral to GP, MI
Dyslipidaemia S-cholesterol ]7.5 mmol/L Referral to GP, MI
Known CVD or diabetes and ]3.5 mmol/L
a Referral to GP, MI
 6.5 mmol/L
a
LDL-cholesterol ]6 mmol/L Referral to GP, MI
Triglycerides ]4 mmol/L Referral to GP, MI
Glucose
regulation
Fasting plasma glucose (capillary) Impaired fasting glucose (IFG): fasting plasma
glucose 6.16.9 mmol/L
a
Follow up visit to nurse
every second year, MI
2 h plasma glucose Impaired glucose tolerance (IGT): fasting plasma
glucose B7.0 and 2 h plasma glucose 8.912.1
mmol/L
a
Follow up visit to nurse
every second year, MI
Diabetes: fasting plasma glucose ]7.0 or/and 2 h
plasma glucose ]12.2 mmol/L
Referral to GP, MI
Metabolic
syndrome
b
Referral to GP, MI
Alcohol CAGE
c (four questions)  2 yes answers of four MI
AUDIT
c Hazardous/harmful alcohol consumption: men
815 points, women 613 points
MI
Alcohol abuse/dependence: men ]16 points,
women ]14 points
Tobacco Number of cigarettes smoked or
boxes of snus consumed
 0M I
aAdditional samples of blood are sent to the Department of Clinical Chemistry at the nearest local hospital for more detailed analysis of
blood lipids including serum cholesterol, LDL-cholesterol, HDL-cholesterol and serum triglycerides.
bMetabolic syndrome defined as: diabetes or IFG or IGT plus two or more of the following: (1) body mass index ]30 kg/m
2 or waist
circumference  102 cm for men or  88 cm for women; (2) blood pressure ]140/90 or current use of antihypertensive medication; (3)
triglycerides  2 mmol/L or HDL-cholesterol 51.0 mmol/L or current use of medication for dyslipidaemia.
cCAGE-questionnaire (Cut down, Annoyance, Guilt, Eye opener) (25); AUDIT-questionnaire (The Alcohol Use Disorder Identification
Test) (32).
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with the participant and provide a comprehensive ap-
proach to facilitate health promotion. To this end, in the
late 1990s, family doctors and district nurses across the
entire county were trained in the method of motivational
interviewing (28). Motivational interviewing uses open
questions, active listening and summaries, as a means of
reinforcing lifestyle changes and aligning them with the
individual’s own conclusions and preferences regarding
conceivable lifestyle changes. During the dialogue, a ‘star-
profile’ is drawn that represents risk markers (Fig. 4); the
more risk indicators, the smaller the points of the star.
While none has a perfect nine-point star, this usefully
illustrates the interrelationships between risk markers and
behaviour, as well as options for health promotion.
Appropriate follow-up visits are recommended and
depending on risk marker levels, participants are referred
to their family doctor for further assessment. When
needed, pharmacologic treatment is provided according
to current guidelines. A significant methodological im-
provement was the implementation of EviBase in 2004:
EviBase is a computerised decision support system.
Measured values of height, weight, blood pressure,
plasma glucose and lipids, as well as questionnaire data
on smoking, history and a family history of CVD and
medication are put into the system by the nurse. The
output is an interpretation including a recommended
action plan that follows the VIP manual and this is used
in the discussion with the participant. This system was
invented and developed by a general practitioner, Mats
Persson (29).
Scientific board, updating procedures and the
administrative system
From its inception, the VIP was supported by a scientific
advisory group from Umea ˚ University. The board
represented internal medicine, social medicine, nutritional
research, family medicine, pedagogy and epidemiology.
This board determined the contents of the health
examination and questionnaire, as well as the manual
for management of results, e.g. cut-off values for recom-
mended follow-up visits or referral to a physician. This
advisory group was disbanded in1995 when the VIP was
integrated into daily primary care routines, and the
County Council’s Division for Research and Develop-
ment (R&D) took responsibility for co-ordination of the
VIP activities and annual training arrangements for
personnel. In March 2005, a new scientific board was
established, which is managed by the head of R&D and
includes representatives with scientific and statistical
competency, primary care expertise and is assisted by
co-ordinating staff. Applications to use data from the
VIP database for research purposes are evaluated and
decided upon by this board. Decisions regarding material
from the stored blood samples with corresponding VIP
data are managed by the board of the Medical Biobank.
The VIP manual has been updated regularly according
to current national and international guidelines (30). In
2003, metabolic syndrome was adopted as a tool to
identify participants with a particularly high CVD risk.
In the same year, measurement of waist circumference
and the intermediate risk state of impaired fasting
glucose (IFG) were also introduced. The questionnaire
has gradually expanded, and the food frequency ques-
tionnaire has been modified and shortened. An addi-
tional questionnaire regarding health-related quality
of life, the Short Form Health Survey (SF-36) (31),
was included in 2003. In 2005, questions about sleep
apnoea and snoring and the AUDIT questionnaire with
Table 3. Overview of Va ¨sterbotten Intervention Programme
questionnaire
Area Variables
Socioeconomic
conditions
Marital/civil status
Housing conditions
Educational level
Occupation
Employment
Sick leave/pension
Ethnicity
Health Self-reported health
Family history of myocardial infarction,
stroke, diabetes
Personal history of diabetes, myocardial
infarction
Current pharmacologic treatment
Health-related quality
of life
Go ¨teborg Quality of Life Instrument
SF-36
Social support and
network, work stress
ISSI (Interview Schedule for Social
Interaction)
Karasek demand/control model
Physical activity Commuting activity
Physical activity at work
Leisure activities
Physical exercise
Tobacco Smoking habits
Use of Swedish moist snuff (snus)
Alcohol CAGE
AUDIT
Sleeping habits Daytime sleepiness, snoring, history of
sleep apnoeas
Eating habits Breakfast habits and daily meals,
portion size, vegetarianism, dietary
supplements
Food frequency
questionnaire
66 items, 8 alternatives from never to
4 times or more every day
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September 2009, the use of Reflotrons has finished and
all analyses of plasma lipids are now done with routine
methods in the clinical chemistry department of the local
hospital. From the same time point, blood pressure is
measured twice with the subject sitting and after 5 min
rest. The mean value for the two measurements is
registered. Completed questionnaires have been optically
read since 1993.
To promote follow-up activities, yearly data sheets are
sent to each VIP nurse, which lists participants who
fulfilled specific criteria during the previous year and
require follow up, according to the VIP manual.
Funding of the VIP
All activities required to co-ordinate the health surveys in
daily practice, including blood sampling, are managed by
the County Council and funded by regional taxes.
Primary care centres are paid 650 SEK ( 80 USD)
for each completed VIP health survey. There are no
contributions from national taxes or private funding.
According to current legislation, the County Council
owns and is responsible for holding and managing the
primary VIP database.
Scientific opportunities and potential
The construction of the VIP enables different types of
study design (Fig. 5). Cross-sectional data comprising
large amounts of information are used to investigate
prevalence and trends in distribution of single markers or
clusters of markers among the population or subpopula-
tions over time. For example, biologic and psychosocial
risk markers and lifestyle patterns can be studied (3335).
Shifts in risk marker distribution following societal
changes or medical interventions may be demonstrated
(36). Based on associations between exposure and out-
come, new hypothesis can then be formulated and further
studies planned.
Nested case-control studies have the strength of pro-
spective studies and are based on the well-defined VIP
population that represents the more general middle-aged
population. Associations may be evaluated at an indivi-
dual level between baseline variables, including those
analysed from stored blood samples, and a wide range of
Fig. 4. The star-proﬁle. Collection of data for blood pressure, body mass index (BMI), plasma glucose, blood lipids, level of
physical activity, self-reported health, alcohol consumption (AUDIT) and tobacco habits are marked. Participants estimate their
own dietary and eating habits. The example illustrates results at baseline and follow up.
The Va ¨sterbotten Intervention Programme
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suggest new hypotheses regarding causal links. Long-
itudinal observations from panel data are used to
investigate incidence as well as associations between
baseline variables and disease at follow up (39, 40).
Supplementary studies based on quantitative data and
adopting qualitative methodologies may deepen existing
research questions (41).
Furthermore, linkages between the VIP and other local,
regional and national databases provide opportunities for
interdisciplinary research, investigation of various disease
outcomes and assessment of further demographic
and socioeconomic conditions (42) (Fig. 6). There are
opportunities to compare Va ¨sterbotten and other parts of
Sweden, as well as vast potential for consideration from a
global perspective. Thus, linking the VIP data with other
databases enables international research collaborations on
a wide range of disease outcomes (43). It would also
be possible to evaluate VIP interventions by comparing
local and national data regarding CVD morbidity and
mortality.
A large number of publications are based on data
collected in the VIP surveys. These may rely solely or to
some degree on the VIP data and may or may not use
results from analysed stored blood samples. This is
exemplified in Table 4, which is a listing of selected
theses defended at Umea ˚ University.
Discussion
The first CVD prevention trials were conducted in the
1960s using a clinical approach and focusing on single
risk factors, in particular hypercholesterolemia and
hypertension. High risk individuals were identified by
means of screening procedures (often directed solely at
men) conducted by medical staff and medical treatment
was often advocated.
A second approach was launched in the 1970s, based
on experiences from these early prevention trials and a
recognition that most CVD cases occur in the large part
of the population with only modestly increased levels of
several risk factors. Examples of programmes are the
North Karelia Project, the Stanford Five City Multi-
factor Risk Intervention Project and the Minnesota
Fig. 5. Design of the Va ¨sterbotten Intervention Programme (VIP) and illustration of different study designs.
Fig. 6. Potential links between the Va ¨sterbotten Intervention
Programme database and local, regional and national
registers.
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Citation: Global Health Action 2010, 3: 4643 - DOI: 10.3402/gha.v3i0.4643Table 4. Selection of theses defended at Umea ˚ University using results that solely or to some degree are based on data from Va ¨sterbotten Intervention Programme, with or
without analysis of stored blood samples from the Medical Biobank
Author Focus Subject Year
New series
No. Highlights
Rose ´n (66) Public health planning Epidemiology and
Public Health
1987 188 Assesses the potential for using epidemiological data from available registers as a tool for
planning. Community diagnoses to analyse local data and discuss the appropriateness of
different intervention strategies. The case of a community-based intervention for
cardiovascular disease (CVD) prevention in Norsjo ¨,V a ¨sterbotten, is presented.
Bra ¨nnstro ¨m (13) Social epidemiology Epidemiology and
Public Health
1993 383 Analyses participation processes and outcome patterns in a local health programme.
Discusses considering age, gender and social differences in planning and evaluation of CVD
prevention programmes.
Lindholm (67) Health economics Epidemiology and
Public Health
1996 449 Addresses the health economic evaluation of community-based interventions for CVD
prevention with special emphasis on the Va ¨sterbotten Intervention Programme.
Weinehall (15) Community intervention
and CVD prevention
Epidemiology and
Public Health
1997 531 Evaluates VIP from a primary health care perspective. Individual attention provided by
primary care promoted risk reduction and benefits to those with low education.
Lindahl (68) Insulin resistance in CVD
and diabetes
Medicine 1998 552 Determines the prevalence of the insulin resistance syndrome and impaired glucose
tolerance. Proinsulin identified as a risk marker of acute myocardial infarction. The CV risk
profile was improved by a behavioural intervention programmme.
So ¨derberg (69) Leptin and CVD Medicine 1999 614 Evaluates the role of leptin, in combination with obesity, in the link between insulin
resistance syndrome (IRS) and CVD.
Rolandsson (70) Autoimmune diabetes Family Medicine 2002 778 Investigates auto-antibodies against pancreatic cell antigens in the population. Body mass
index as effective as glucose values in predicting diabetes. Obesity suggested to be an
accelerator of type 1 diabetes
Johansson (71) Haemostatic factors
predicting CVD
Medicine 2002 815 Evaluated haemostatic factors predicting stroke and myocardial infarction and concluded
that, in addition to traditional cardiovascular risk factors, they carry predictive information on
the risk of CVD.
Persson (72) Hypertension drug
treatment
Family Medicine 2003 837 Diagnosed hypertension is not controlled according to guidelines. This, as well as diabetes
or untreated hypertension, increases the risk of stroke. A clinical decision support system
was constructed that could reduce drug costs and enhance the quality of hypertension drug
treatment.
Emmelin (73) Self-rated health in CVD
prevention
Epidemiology and
Public Health
2004 884 Discusses the ethical platform of community interventions and suggests self-rated health as
an unexplored indicator, potentially important for understanding the complexity of
community interventions.
Karlsson (74) Metabolic disturbances
and shift work
Occupational
Medicine
2004 891 Metabolic risk factors were associated with shift work. Shift work was associated with
increased risk for coronary heart disease (CHD), diabetes and ischemic stroke, but not with
increased total mortality.
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Author Focus Subject Year
New series
No. Highlights
Hultdin (75) Homocysteine Medical
Chemistry
2005 969 Total plasma homocysteine levels and the main genetic determinant MTHFR are
independent risk factors for first stroke but not ischemic stroke. Myocardial infarction does
not increase homocysteine levels.
Tho ¨gersen (76) Risk factors of myocardial
infarction
Medicine 2005 975 Specific biomarkers related to fibrinolysis and lipoprotein systems may improve the
prediction of a first myocardial infarction. A high creatinine value was associated with
increased risk of first myocardial infarction.
Wiklund (77) Genetic aspects of stroke Medicine 2005 999 The genetic component in causation of stroke was investigated. PAI-1 genotype association
with risk of future ischemic stroke. This interacted with the modifiable risk marker
triglyceride level.
Berglin (78) Rheumatoid arthritis Medicine 2006 1001 Anti-CCP antibodies and IgA-RF are predictors of future RA and radiological progression.
Therapeutic response decreases radiological progression and bone-loss as well as lowers
the level of anti-CCP.
van Guelpen (79) Folate in cancers and CVD Medical
Chemistry
2006 1049 A high folate status may reduce the risk of CVD. Increased folate and B12 levels might be
associated with carcinogenesis. This may have implications for the debate concerning folate
fortification of foods.
Nafziger (80) Obesity prevention Epidemiology and
Public Health
2006 1050 BMI increases similarly in Sweden and the USA. More adult Swedes maintained weight in
recent years. The proportion of weight-gaining adults with identified CVD risk factors is
smaller than those without. Obesity prevention should target those usually considered low
risk.
Norberg (81) Early risk markers of
type 2 diabetes
Family Medicine
and Epidemiology
2007 1077 Common clinical markers are sufficient for identification of subjects at risk for type 2
diabetes (T2D). Psychosocial stress increases the risk for T2D in women. Snuff is an
independent risk marker of obesity.
Krachler (82) Diet and CVD Medicine 2007 1108 Describes changes in dietary habits and their relative importance as risk factors for diabetes
and CVD. Potential goals for interventions are suggested.
Johansson (83) Prostate cancer
epidemiology
Urology and
Andrology
2008 1165 Genetic variations associated with risk of prostate cancer and with prostate-cancer-specific
survival are evaluated. Further studies for confirmation are needed.
Wennberg (84) Physical activity and
coronary heart disease
Family Medicine 2009 1245 Active commuting reduces, but the use of snuff did not increase the risk of myocardial
infarction. Haemostatic and inflammatory markers may enhance the predictive ability of
established risk factors.
Stocks (85) Metabolic factors and
cancer
Urology and
Andrology
2009 1267 Elevated blood glucose increases the risk of several cancers. Overweight and metabolic
aberrations increase the risk of colorectal cancer in an additive way, but reduce the risk of
incident prostate cancer, whereas overweight increases the risk of fatal prostate cancer.
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3Heart Health Program, which were centrally adminis-
tered on a large scale and combined population and high-
risk approaches with a focus on traditional major CVD
risk factors.
The VIP belongs to a third generation of prevention
programmes, introduced in the 1980s, which build on
existing local structures, are small scale, action oriented
and combine a broad low-risk population and high-risk
individual strategies. They include biomedical risk factors
and psychosocial and socioeconomic living conditions.
The information and dialogue that conclude each health
survey complement activities in the local community
to form a population-based intervention. In the VIP,
primary care continuously promotes prevention efforts in
a stable, well-established and familiar structure within the
local community. This enables endurance and sustain-
ability in a way that a research project is seldom able to
achieve. Opportunities to detect participants at high
CVD risk and subsequently implement secondary pre-
vention measures add extra value to these efforts.
The simple strategy is to offer a health examination
and accompanying dialogue with a VIP nurse to every
middle-aged Va ¨sterbotten inhabitant every 10 years. In
fact, to undergo a health survey at regular intervals,
comparable to mandated Swedish motor vehicle inspec-
tions, was originally suggested by an elderly Norsjo ¨
resident (44). By the end of 2007, more than 86,000
(51% women) individuals had participated in the VIP and
almost 27,000 (53% women) had done so twice. The
pioneer Norsjo ¨ group is now in their third round of
examinations. The potential for the spread of positive
attitudes and improved health literacy cannot be fully
estimated despite the fact that each participant knows
that there will be a follow-up survey after 10 years, which
may reinforce willingness to develop healthy habits (45).
Evaluations in Norsjo ¨ show that local activities, the
health survey and counselling, local information papers
and the food labelling system were regarded as being the
most influential motivators for individuals to make
healthy lifestyle changes (44). Indeed, 2007 data from
the National Institute of Public Health reveal that the
population in Va ¨sterbotten County in 2007 reported
healthier lifestyle habits as well as better self-reported
health among men compared with other counties (46).
The 10-year evaluation of the VIP showed that
reductions in cholesterol and blood pressure levels were
significantly greater in the Norsjo ¨ area as compared to a
reference area in Northern Sweden, and that the health
gap between the socially privileged and less privileged
had narrowed (47). Similar results were also reported
from similar intervention programmes in the South of
Sweden (48). More recently, Denmark’s Ebeltoft Health
Promotion Project has provided further support for this
idea through a randomised controlled trial, which
indicated high participation rates for general health
screenings and consultations in family practices to
address CVD risk. These interventions resulted in
reduced CVD risk and increased life expectancy without
any negative long-term psychological reactions or in-
creased health care contacts compared to the control
group (49). Evaluations showed cost effectiveness in life
years gained (50), and the need for health professionals to
be aware of an individual’s willingness or potential to
achieve suggested lifestyle changes (51).
Strengths and weaknesses of the VIP
The combination of low-risk population and high-risk
individual strategies creates opportunities for active
participation and intervention by the general population.
Evaluations show that the primary health care strategy
accelerates risk factor reduction that has been achieved
by the population-oriented strategy (15). Swedish district
nurses possess credibility and are highly respected among
the population, and the fact that the VIP participants
meet a district nurse generates a good grounding for
health promotion. This also contributes to the longevity
of the VIP and its high participation rates. A further
strength is the use of motivational interviewing for the
health survey, counselling and follow up. Moreover,
the link from survey participation to care is rapid and
made as reassuring as possible, since high-risk partici-
pants are referred to their usual family doctor for
evaluation and medical treatment. Additional value can
be found in the integration of the VIP data with ordinary
case records, so that the former are available to and useful
for physicians in consultations not directly connected to
the VIP.
The VIP data also have obvious added values for
planning and resource allocation by health care providers
and managers. The scientific board, which supervises and
updates the procedures and health survey manual, and
the County Council co-ordinating staff ensure that the
VIP operates according to current scientific evidence.
Low participation rates, around 50%, at the beginning
of the 1990s mirrored both the independent role of the
health centres and their different prioritisation strategies.
The extent of individual VIP nurses to be the driving
force for the VIP may also contribute to differences
between health centres regarding participation rates. This
was handled by the authority, the County Council, by the
decision to integrate the VIP in prescribed routines and
to pay only for completed health examinations. This
political determination from the very start of the VIP, to
give priority to prevention, probably contributes to the
longevity of the VIP not being dependent on local
enthusiasts. Indeed, the questioning of the VIP has
been and is still obvious among some health care staff,
not least among doctors, but to a much lesser degree
during recent years. The need for support, not only from
politicians and the VIP administration, but also from
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Evaluation of complex interventions
In 1997, the Swedish Council on Technology Assessment
in Health Care conducted a systematic review of com-
munity prevention programmes launched in the 1970s
and 1980s (52). Only eight programmes fulfilled the
evaluation criteria: targeting multiple risk factors, includ-
ing a reference population, and outcomes reported and
published as changes in CVD risk factors or disease. The
North Karelia Project (53) and the large American trials,
i.e. the Stanford Five City project (54), the Minnesota
Heart Health Program (55) and the Pawtucket Heart
Health Program (56), were included. The review con-
cluded that no reliable effects could be demonstrated in a
reduction of risk factor levels or morbidity within the
intervention areas beyond those in society as a whole.
However, local health care providers did not play
a leading part in the above-mentioned US interventions
and therefore the 1997 Swedish evaluation concluded that
it would be difficult to estimate possible consequences if
primary care played a crucial role (52). Experiences from
the three US projects indicated that active participation
by community health professionals would have strength-
ened these projects (57), and although not a driving force,
the North Karelia project demonstrated the potential of
primary care in prevention. The VIP, belonging to the
third generation of intervention programmes, should
therefore not be dismissed based on evaluations that
apply methods designed for evaluation of randomised
clinical trials and that have failed to show effects in earlier
prevention programmes.
Due to different types of dilution bias, it is argued that
intermediate outcomes (e.g. risk factor levels rather than
morbidity and mortality) should be used for evaluation of
community interventions (58). A more multidisciplinary,
problem-oriented strategy to evaluate community inter-
ventions that use longitudinal analyses and several
methods to identify critical points from baseline to a
follow-up outcome is also proposed (44, 59, 60). The VIP
fulfils criteria for complex interventions (61, 62) and
therefore its evaluation demands research that aims to
understand the process of implementing and maintaining
the VIP, evaluation of feasibility, methodology and effects
of health counselling from both provider and participant
perspectives. As the development of CVD and diabetes
spans decades, long-term follow up is necessary for
evaluations of morbidity and mortality outcomes (63
65). Obviously, the evaluation of the intervention in the
VIP and the VIP as a long-term activity is still a challenge
and much work remains to be done.
Implications from the VIP
The concept of the VIP, established as a collaboration
between politicians and health care providers on the one
side and primary care and the public on the other, forms
the basis for effective implementation and endurance over
time. A core component in the VIP is the active
involvement of primary care, which functions as the
operating machinery. The VIP data have the potential to
explore disease outcomes from several perspectives,
beyond the current mapping of risk markers or protective
(salutogenic) factors, socioeconomic conditions, lifestyle
habits and their possible associations with CVD risk
markers and diabetes. The VIP may also provide data to
evaluate the predictive validity of risk markers and the
requirements for successful intervention. In this way, the
VIP may contribute to the development of prevention
methods. Blood samples stored in the Medical Biobank
enable investigation of a wide range of diseases in
prospective case-referent and panel studies, including
cancers, neurological, inflammatory and infectious dis-
eases, and others, in addition to CVD and diabetes.
Comprehensive demographic data and causes-of-death
statistics have been collected in Sweden since the 18th
century. Census data now also include information on
socioeconomic conditions (e.g. education, housing, occu-
pation and income, employment and unemployment,
migration, sick leave and parental leave). There are
many other registers (e.g. a register linking generations,
a twin register, medical birth registration, the collection
of health data in child and maternal welfare clinics,
dental care, somatic and psychiatric diagnoses for hospi-
tal inpatients and outpatients). Furthermore, an increas-
ing number of national registers are built on diagnoses,
e.g. cancers, myocardial infarction, stroke or diabetes.
Every Swedish citizen has a unique civic number
facilitating record linkage and comprehensive analyses
of dropout frequencies and distributions of non-partici-
pation. The VIP provides extensive opportunities to
link local, regional and national registers and databases
in order to explore a wide range of scientific questions
(Fig. 6). Most research projects that are based on the VIP
data, with or without accompanying data from samples
in the Medical Biobank, would be impossible to carry out
if they had to be organised or financed by individual
research groups.
Conclusion
After more than 20 years of the VIP, there is a large,
comprehensive, population-based database, a stable or-
ganisation to conduct health surveys and collect data,
established expectations among middle-aged citizens to
be regularly offered a VIP examination, and a solid
structure to enable widespread multidisciplinary and
international scientific collaboration. The value of the
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